𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estimating Effect Sizes in Genome-Wide Association Studies

✍ Scribed by József Bukszár; Edwin J. C. G. van den Oord


Publisher
Springer US
Year
2010
Tongue
English
Weight
333 KB
Volume
40
Category
Article
ISSN
0001-8244

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Machine learning in genome-wide associat
✍ Silke Szymczak; Joanna M. Biernacka; Heather J. Cordell; Oscar González-Recio; I 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

Recently, genome-wide association studies have substantially expanded our knowledge about genetic variants that influence the susceptibility to complex diseases. Although standard statistical tests for each single-nucleotide polymorphism (SNP) separately are able to capture main genetic effects, dif

X chromosome association testing in geno
✍ Peter F. Hickey; Melanie Bahlo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Genome wide association studies (GWAS) have revealed many fascinating insights into complex diseases even from simple, single-marker statistical tests. Most of these tests are designed for testing of associations between a phenotype and an autosomal genotype and are therefore not applicable to X chr

Genome-wide association studies for disc
✍ Duncan C. Thomas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract Genome‐wide association studies of discrete traits generally use simple methods of analysis based on χ^2^ tests for contingency tables or logistic regression, at least for an initial scan of the entire genome. Nevertheless, more power might be obtained by using various methods that anal

Risk prediction using genome-wide associ
✍ Charles Kooperberg; Michael LeBlanc; Valerie Obenchain 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB 👁 1 views

## Abstract Over the last few years, many new genetic associations have been identified by genome‐wide association studies (GWAS). There are potentially many uses of these identified variants: a better understanding of disease etiology, personalized medicine, new leads for studying underlying biolo